ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Condition : By Disease Heading : Cancers and other Neoplasms : Carcinoma, Hepatocellular

Include trials that are no longer recruiting patients.

59 studies were found. Here are studies 1 to 50.
1.RecruitingChemotherapy in Treating Children With Liver Cancer
Conditions: childhood hepatoblastoma; childhood hepatocellular carcinoma; childhood liver cancer
2.RecruitingStudy of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma; Liver Cancer
3.RecruitingStudy of DENSPM in Patients with Liver Cancer who are Not Eligible for Surgical Cure
Condition: Carcinoma, Hepatocellular
4.RecruitingVaccine Therapy in Treating Patients With Liver Cancer
Conditions: localized resectable adult primary liver cancer; localized unresectable adult primary liver cancer; advanced adult primary liver cancer; ...
5.RecruitingA Study to Estimate Safety and Efficacy of Bay 43-9006 in the Treatment of Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
6.RecruitingVaccine Therapy in Treating Patients With Stage II, Stage III, or Stage IVA Liver Cancer
Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized resectable adult primary liver cancer; ...
7.RecruitingDoxorubicin and Bortezomib in Treating Patients With Liver Cancer
Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
8.RecruitingBortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)
Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
9.RecruitingTAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
Conditions: advanced adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma; ...
10.RecruitingEpirubicin and Thalidomide in Treating Patients With Liver Cancer
Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
11.RecruitingOxaliplatin in Treating Patients With Liver Cancer
Conditions: advanced adult primary liver cancer; localized unresectable adult primary liver cancer; recurrent adult primary liver cancer; ...
12.RecruitingErlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction
Conditions: recurrent adult primary liver cancer; localized unresectable adult primary liver cancer; advanced adult primary liver cancer; ...
13.RecruitingOblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
14.RecruitingNolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer
Conditions: localized unresectable adult primary liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
15.RecruitingChemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver
Conditions: localized unresectable adult primary liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
16.RecruitingHeat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors
Conditions: advanced adult primary liver cancer; liver metastases; localized unresectable adult primary liver cancer; recurrent adult primary liver cancer
17.RecruitingIrinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer
Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; recurrent adult primary liver cancer
18.RecruitingPositron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer
Conditions: adult primary hepatocellular carcinoma; recurrent adult primary liver cancer; localized resectable adult primary liver cancer
19.RecruitingEpirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma Cancer
Conditions: advanced adult primary liver cancer; localized unresectable adult primary liver cancer; adult primary hepatocellular carcinoma
20.RecruitingBevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer
Conditions: adult primary hepatocellular carcinoma; recurrent adult primary liver cancer; localized unresectable adult primary liver cancer
21.RecruitingChemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery
Conditions: localized unresectable adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma
22.RecruitingErlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed
Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer
23.RecruitingMegestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Conditions: localized unresectable adult primary liver cancer; advanced adult primary liver cancer; adult primary hepatocellular carcinoma
24.RecruitingHepatic Arterial Infusion Plus Internal Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Conditions: localized unresectable adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma
25.RecruitingThalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery
Conditions: localized unresectable adult primary liver cancer; advanced adult primary liver cancer; adult primary hepatocellular carcinoma
26.RecruitingA Trial of Thymalfasin in Adult Patients with Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
27.RecruitingSafety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation
Conditions: Liver Transplantation; Hepatitis; Cholestasis; Carcinoma, Hepatocellular
28.RecruitingTesting of ADI-PEG in Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
29.RecruitingBMS-247550 in Treating Patients With Liver or Gallbladder Cancer
Conditions: adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer
30.RecruitingBortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction
Conditions: adult non-Hodgkin's lymphoma; adult primary liver cancer; adult solid tumor
31.RecruitingBortezomib as First-Line Systemic Therapy in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder
Conditions: adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer
32.RecruitingAdjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer
Conditions: adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer; Pain
33.RecruitingRebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer
Conditions: adult primary liver cancer; cholangiocarcinoma of the extrahepatic bile duct; cholangiocarcinoma of the gallbladder; ...
34.RecruitingDoxorubicin With or Without Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
Conditions: advanced adult primary liver cancer; adult primary hepatocellular carcinoma
35.RecruitingRadioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer
Conditions: localized resectable adult primary liver cancer; adult primary hepatocellular carcinoma
36.RecruitingCombination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer
Conditions: stage I childhood liver cancer; recurrent childhood liver cancer; childhood hepatoblastoma
37.RecruitingSafety and Tolerability of I.V. Infusion of MB07133 in Patients with Unresectable Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
38.RecruitingPrevention of Recurrent Hepatitis B after Liver Transplantation
Conditions: Hepatitis B; Cirrhosis; Acute Liver Failure; Hepatocellular Carcinoma
39.RecruitingLiver Perfusion for Patients with Inoperable Liver Cancer
Condition: Liver Cancer
40.RecruitingCombination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
Condition: Cancer
41.RecruitingEF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal Cancer
Conditions: Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; musculoskeletal cancer; unclassified and other cancer
42.RecruitingErlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
Condition: Cancer
43.RecruitingVaccine Therapy in Treating Patients With Advanced or Metastatic Cancer
Conditions: Breast Cancer; Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; Head and Neck Cancer
44.RecruitingArsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors
Condition: childhood cancer
45.RecruitingCapecitabine Combined with Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Breast Cancer; Gastrointestinal Cancer; Head and Neck Cancer; thorax and respiratory cancer; unclassified and other cancer
46.RecruitingChronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular Cancer
Condition: Liver Cancer
47.Not yet recruitingOxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment
Condition: Cancer
48.RecruitingIntravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Condition: Cancer
49.RecruitingIntravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Condition: Cancer
50.RecruitingThalidomide and Docetaxel in Treating Patients With Advanced Cancer
Condition: Cancer

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act